Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical ...
In May 2024, the Food and Drug Administration (FDA) approved two new cervical screening tests for detecting human papillomavirus (HPV), which causes almost all cervical cancers. Both allow individuals ...
Transient HPV is the norm, whereas persistent high-risk HPV over years drives cervical dysplasia and malignant transformation, supporting longitudinal surveillance when high-risk types are identified.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results